They observed that TFPI-2 is significantly down-regulated by microRNA-616 (miR-616) in androgen-independent prostate cancer cell lines compared with androgen-dependent prostate cancer cell lines or normal prostate cells and may contribute to disease progression and resistance to treatment in prostate cancer. The gene discussed is TFPI2; the disease is prostate cancer.